Author: Nichols Martin|| Date Published: December 21, 2018
Richard Pilch, who previously managed countless programs in support of the Defense Threat Reduction Agency, has joined Noblis as director of chemical, biological, radiological, nuclear and explosives programs.
He will lead the Reston, Va.-based contractor’s portfolio of CBRNE research, development, test and evaluation, systems engineering and integration activities, Noblis said Dec. 13.
Pilch previously managed several DTRA initiatives such as the Scientific and Technical Engagement Partnership. The trained medical doctor has also led biodefense and biosecurity programs throughout his career.
œWe welcome Dr. Pilch to our team as we move forward in our mission to protect, strengthen and advance our nation™s national security posture side-by-side with our federal clients,” said Jordin Cohen, vice president of defense and homeland security at Noblis.
The Space Development Agency has awarded $3.5 billion in other transaction authority agreements to Lockheed Martin, L3Harris Technologies, Northrop Grumman…
The Defense Health Agency has awarded TriWest Healthcare Alliance $6.8 billion to continue providing healthcare and administrative services in support…
Richard Pilch, who previously managed countless programs in support of the Defense Threat Reduction Agency, has joined Noblis as director of chemical, biological, radiological, nuclear and explosives programs.
